Cardiovascular Outcomes in Framingham Participants With Diabetes The Importance of Blood Pressure

被引:207
|
作者
Chen, Guanmin [1 ]
McAlister, Finlay A. [2 ,3 ]
Walker, Robin L. [1 ]
Hemmelgarn, Brenda R. [1 ]
Campbell, Norm R. C. [1 ]
机构
[1] Univ Calgary, Dept Med, Calgary, AB, Canada
[2] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada
[3] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada
基金
加拿大健康研究院;
关键词
diabetes mellitus; hypertension; Framingham; population-attributable risk; TERM-FOLLOW-UP; RISK; MELLITUS; EVENTS; DISEASE; HYPERTENSION; MORTALITY; ADULTS;
D O I
10.1161/HYPERTENSIONAHA.110.162446
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We designed this study to explore to what extent the excess risk of cardiovascular events in diabetic individuals is attributable to hypertension. We retrospectively analyzed prospectively collected data from the Framingham original and offspring cohorts. Of the 1145 Framingham subjects newly diagnosed with diabetes mellitus who did not have a previous history of cardiovascular events, 663 (58%) had hypertension at the time that diabetes mellitus was diagnosed. During 4154 person-years of follow-up, 125 died, and 204 experienced a cardiovascular event. Framingham participants with hypertension at the time of diabetes mellitus diagnosis exhibited higher rates of all-cause mortality (32 versus 20 per 1000 person-years; P<0.001) and cardiovascular events (52 versus 31 per 1000 person-years; P<0.001) compared with normotensive subjects with diabetes mellitus. After adjustment for demographic and clinical covariates, hypertension was associated with a 72% increase in the risk of all-cause death and a 57% increase in the risk of any cardiovascular event in individuals with diabetes mellitus. The population-attributable risk from hypertension in individuals with diabetes mellitus was 30% for all-cause death and 25% for any cardiovascular event (increasing to 44% and 41%, respectively, if the 110 normotensive subjects who developed hypertension during follow-up were excluded from the analysis). In comparison, after adjustment for concurrent hypertension, the population-attributable risk from diabetes mellitus in Framingham subjects was 7% for all-cause mortality and 9% for any cardiovascular disease event. Although diabetes mellitus is associated with increased risks of death and cardiovascular events in Framingham subjects, much of this excess risk is attributable to coexistent hypertension. (Hypertension. 2011;57:891-897.) . Online Data Supplement
引用
收藏
页码:891 / U65
页数:16
相关论文
共 50 条
  • [41] Within-Visit Blood Pressure Variability and Cardiovascular Risk in ELSA-Brasil Study Participants
    Zarife, Andre Sant'Anna
    Fraga-Maia, Helena
    Mill, Jose Geraldo
    Lotufo, Paulo
    Griep, Rosane Harter
    Mendes da Fonseca, Maria de Jesus
    Brito, Luciara Leite
    Almeida, Maria da Conceicao
    Aras, Roque
    Alvim Matos, Sheila Maria
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2022, 119 (04) : 505 - 511
  • [42] Dapagliflozin and cardiovascular outcomes in patients with Type 2 diabetes
    Al-Bazz, Dalai Y.
    Wilding, John P. H.
    FUTURE CARDIOLOGY, 2020, 16 (02) : 77 - 88
  • [43] Blood pressure measurement for prediction of chronic pressure overload and cardiovascular events
    Auer, Johann
    Weber, Thomas
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (01)
  • [44] Single Versus Combined Blood Pressure Components and Risk for Cardiovascular Disease The Framingham Heart Study
    Franklin, Stanley S.
    Lopez, Victor A.
    Wong, Nathan D.
    Mitchell, Gary F.
    Larson, Martin G.
    Vasan, Ramachandran S.
    Levy, Daniel
    CIRCULATION, 2009, 119 (02) : 243 - U69
  • [45] Confirming the critical importance of blood pressure control in people with diabetes
    Campbell, Norm R. C.
    Leiter, Lawrence A.
    Larochelle, Pierre
    Tobe, Sheldon
    Chockalingam, Arun
    Ward, Richard
    Morris, Dorothy
    Tysuyuki, Ross
    CANADIAN JOURNAL OF CARDIOLOGY, 2009, 25 (10) : 594 - 595
  • [46] Representativeness of randomized controlled trials participants on the effect of continuous positive airway pressure on cardiovascular outcomes: caution is needed
    Angel Martinez-Garcia, Miguel
    Oscullo, Grace
    Daniel Gomez-Olivas, Jose
    SLEEP, 2022, 45 (04)
  • [47] Urine Ammonium Concentrations and Cardiovascular and Kidney Outcomes in Systolic Blood Pressure Intervention Trial Participants with CKD
    Bullen, Alexander L.
    Katz, Ronit
    Seegmiller, Jesse
    Garimella, Pranav S.
    Ascher, Simon B.
    Rifkin, Dena E.
    Raphael, Kalani L.
    Shlipak, Michael G.
    Ix, Joachim H.
    KIDNEY360, 2024, 5 (08): : 1077 - 1086
  • [48] Associations of blood pressure with cardiovascular and mortality outcomes in over 2 million older persons with or without diabetes mellitus: A systematic review and meta-analysis of 45 cohort studies
    Seidu, Samuel
    Hambling, Clare E.
    Kunutsor, Setor K.
    Topsever, Pinar
    PRIMARY CARE DIABETES, 2023, 17 (06) : 554 - 567
  • [49] Association betweenMRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease
    Lorbeer, Roberto
    Bayerl, Christian
    Auweter, Sigrid
    Rospleszcz, Susanne
    Lieb, Wolfgang
    Meisinger, Christa
    Heier, Margit
    Peters, Annette
    Bamberg, Fabian
    Hetterich, Holger
    JOURNAL OF HYPERTENSION, 2017, 35 (04) : 737 - 744
  • [50] Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure
    Melgarejo, Jesus D.
    Yang, Wen-Yi
    Thijs, Lutgarde
    Li, Yan
    Asayama, Kei
    Hansen, Tine W.
    Wei, Fang-Fei
    Kikuya, Masahiro
    Ohkubo, Takayoshi
    Dolan, Eamon
    Stolarz-Skrzypek, Katarzyna
    Huang, Qi-Fang
    Tikhonoff, Valerie
    Malyutina, Sofia
    Casiglia, Edoardo
    Lind, Lars
    Sandoya, Edgardo
    Filipovsky, Jan
    Gilis-Malinowska, Natasza
    Narkiewicz, Krzysztof
    Kawecka-Jaszcz, Kalina
    Boggia, Jose
    Wang, Ji-Guang
    Imai, Yutaka
    Vanassche, Thomas
    Verhamme, Peter
    Janssens, Stefan
    O'Brien, Eoin
    Maestre, Gladys E.
    Staessen, Jan A.
    Zhang, Zhen-Yu
    HYPERTENSION, 2021, 77 (01) : 39 - 48